Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) and DMK Pharmaceuticals, Corp. is fair to Adamis shareholders. Halper Sadeh encourages Adamis shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or
[email protected] or
[email protected] . The investigation concerns whether Adamis and its board violated the federal...